ICER Priced Tavapadon Before the FDA Approved It or AbbVie Named a Price
An assessment body has priced a drug that has neither an approval nor a price. The number will sit in every payer negotiation that follows.
Cost Effectiveness
An assessment body has priced a drug that has neither an approval nor a price. The number will sit in every payer negotiation that follows.